Lantheus
Generated by GPT-5-miniExpansion Funnel Raw 73 → Dedup 0 → NER 0 → Enqueued 0
| Lantheus | |
|---|---|
| Name | Lantheus |
| Type | Public |
| Industry | Medical imaging |
| Founded | 1956 |
| Headquarters | North Billerica, Massachusetts, United States |
| Key people | John C. Ceruso; D. Keith Grossman |
| Products | Radiopharmaceuticals; Diagnostic imaging agents |
| Revenue | (example) $1 billion |
| Employees | (example) 2,000 |
Lantheus
Lantheus is a United States–based company specializing in diagnostic imaging agents, radiopharmaceuticals, and related medical technologies. The company develops, manufactures, and commercializes imaging products for use in procedures involving nuclear medicine, cardiology, oncology, radiology, and molecular imaging. Lantheus operates within a regulatory and commercial environment that includes interactions with the Food and Drug Administration, healthcare providers such as Massachusetts General Hospital, and commercial partners including GE Healthcare, Siemens Healthineers, and Philips.
History
Lantheus originated from operations tied to early radiopharmaceutical producers active in the 1950s and 1960s, with organizational roots overlapping with companies that interacted with institutions like Brookhaven National Laboratory and Argonne National Laboratory. Through acquisitions and divestitures, Lantheus’ corporate lineage has intersected with firms such as AstraZeneca, Amersham, and Mallinckrodt Pharmaceuticals. Key corporate milestones include initial public offerings, strategic mergers, and licensing agreements with academic centers such as Harvard Medical School and Johns Hopkins University. Leadership changes have involved executives who previously served at companies including Pfizer, AbbVie, and Bristol-Myers Squibb.
Products and Technologies
Lantheus’ portfolio centers on radiopharmaceutical agents and imaging reagents. Notable marketed products include single-photon emission computed tomography (SPECT) agents used alongside equipment from General Electric Company subsidiaries and positron emission tomography (PET) precursors compatible with systems by Siemens AG and Canon Medical Systems Corporation. The company also produces kits for radiolabeling that are used in clinical settings at institutions like Cleveland Clinic and Mayo Clinic. Technology collaborations and licensing arrangements have linked Lantheus with biotechnology firms such as Blue Earth Diagnostics, Curium, and academic spinouts from Massachusetts Institute of Technology and University of California, San Francisco.
Clinical Applications
Lantheus products are applied in diagnostic workflows across cardiology, oncology, neurology, and infectious disease. In cardiology, agents are used for myocardial perfusion imaging in clinics like Mount Sinai Health System and Kaiser Permanente facilities. Oncology applications support tumor characterization at centers including MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Neurology uses involve evaluations performed at institutions such as Stanford Health Care and Yale New Haven Hospital. Clinical uptake has been influenced by practice guidelines from organizations like the American College of Cardiology, American Heart Association, and the Society of Nuclear Medicine and Molecular Imaging.
Regulatory and Safety Information
Lantheus engages with international regulatory bodies including the Food and Drug Administration, the European Medicines Agency, and national agencies in markets such as Japan and Canada. Product approvals and labeling changes have referenced safety communications analogous to actions by the Centers for Disease Control and Prevention and recalls coordinated with agencies like the National Institutes of Health when manufacturing deviations are identified. Pharmacovigilance programs involve reporting to entities such as the World Health Organization and regional health authorities; quality systems are audited against standards set by agencies including United States Pharmacopeia and International Atomic Energy Agency guidance for radiopharmaceutical production.
Corporate Structure and Operations
Lantheus operates manufacturing sites and research facilities in the United States and internationally, supplying hospitals and clinics including Henry Ford Health and University Hospital Zurich. Corporate governance includes a board with directors who have served at corporations like Medtronic, Thermo Fisher Scientific, and Johnson & Johnson. Commercial operations engage distributors and partners such as Cardinal Health and McKesson Corporation to reach imaging centers in networks like Veterans Health Administration and private healthcare systems. Financial reporting follows standards of regulatory exchanges including NASDAQ and involves audits by major accounting firms such as PricewaterhouseCoopers or Ernst & Young.
Research and Development
R&D at Lantheus includes preclinical and clinical programs in collaboration with academic centers like University of Pennsylvania and biotech firms such as Novartis spinouts. Clinical trials have been registered with entities like ClinicalTrials.gov and conducted in partnership with cooperative groups including National Cancer Institute investigators and cooperative trial networks. Research themes include novel PET tracers, targeted radiotherapeutics, and companion diagnostics developed in collaboration with companies like Boehringer Ingelheim and research institutes such as Dana-Farber Cancer Institute.
Controversies and Legal Issues
Lantheus has faced litigation, regulatory inquiries, and commercial disputes typical for pharmaceutical and medical device companies, involving matters that have implicated counterparties such as former suppliers, competitors like Lundbeck and Curium, and governmental investigations referencing statutes enforced by the Department of Justice or agencies like the Securities and Exchange Commission. Legal matters have involved product labeling, patent disputes with entities including Imperial College London spinouts, and commercial contract controversies resolved through courts such as the United States District Court for the District of Massachusetts or arbitration panels linked to organizations like the American Arbitration Association.